JP2022521859A5 - - Google Patents

Info

Publication number
JP2022521859A5
JP2022521859A5 JP2021571055A JP2021571055A JP2022521859A5 JP 2022521859 A5 JP2022521859 A5 JP 2022521859A5 JP 2021571055 A JP2021571055 A JP 2021571055A JP 2021571055 A JP2021571055 A JP 2021571055A JP 2022521859 A5 JP2022521859 A5 JP 2022521859A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
cycloalkyl
alkoxy
heteroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021571055A
Other languages
English (en)
Japanese (ja)
Other versions
JP7615056B2 (ja
JP2022521859A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2020/074696 external-priority patent/WO2020168939A1/zh
Publication of JP2022521859A publication Critical patent/JP2022521859A/ja
Publication of JP2022521859A5 publication Critical patent/JP2022521859A5/ja
Priority to JP2024231551A priority Critical patent/JP7821259B2/ja
Application granted granted Critical
Publication of JP7615056B2 publication Critical patent/JP7615056B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021571055A 2019-02-19 2020-02-11 複素環化合物、これを含む薬物組成物、その製造方法および使用 Active JP7615056B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024231551A JP7821259B2 (ja) 2019-02-19 2024-12-27 複素環化合物、これを含む薬物組成物、その製造方法および使用

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN201910124584 2019-02-19
CN201910124584.6 2019-02-19
CN201910437878 2019-05-24
CN201910437878.4 2019-05-24
CN201910932095 2019-09-29
CN201910932095.3 2019-09-29
PCT/CN2020/074696 WO2020168939A1 (zh) 2019-02-19 2020-02-11 杂环化合物、包含其的药物组合物及其制备方法和用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024231551A Division JP7821259B2 (ja) 2019-02-19 2024-12-27 複素環化合物、これを含む薬物組成物、その製造方法および使用

Publications (3)

Publication Number Publication Date
JP2022521859A JP2022521859A (ja) 2022-04-12
JP2022521859A5 true JP2022521859A5 (enExample) 2023-08-29
JP7615056B2 JP7615056B2 (ja) 2025-01-16

Family

ID=72143544

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021571055A Active JP7615056B2 (ja) 2019-02-19 2020-02-11 複素環化合物、これを含む薬物組成物、その製造方法および使用
JP2024231551A Active JP7821259B2 (ja) 2019-02-19 2024-12-27 複素環化合物、これを含む薬物組成物、その製造方法および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024231551A Active JP7821259B2 (ja) 2019-02-19 2024-12-27 複素環化合物、これを含む薬物組成物、その製造方法および使用

Country Status (16)

Country Link
US (1) US20220144847A1 (enExample)
EP (1) EP3929198A4 (enExample)
JP (2) JP7615056B2 (enExample)
KR (1) KR102977603B1 (enExample)
CN (3) CN117327078A (enExample)
AU (1) AU2020226422C1 (enExample)
BR (1) BR112021016299A2 (enExample)
CA (1) CA3130245A1 (enExample)
CL (1) CL2021002205A1 (enExample)
CO (1) CO2021011023A2 (enExample)
IL (1) IL285378B2 (enExample)
MX (1) MX2021009971A (enExample)
PH (1) PH12021552004A1 (enExample)
SA (1) SA521430084B1 (enExample)
SG (1) SG11202107848TA (enExample)
WO (1) WO2020168939A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7688690B2 (ja) * 2020-07-28 2025-06-04 スーチュアン・コールン-バイオテック・バイオファーマシューティカル・カンパニー・リミテッド ピリミジン系化合物の塩、結晶形およびその調製方法
WO2022199503A1 (zh) 2021-03-24 2022-09-29 四川科伦博泰生物医药股份有限公司 杂环化合物治疗与激酶耐药突变相关的疾病的用途和方法
CN114235976B (zh) * 2021-11-09 2023-11-03 暨南大学 一种含氮杂环有机化合物中间产物的合成和分析方法
CN120897743A (zh) 2023-05-19 2025-11-04 四川科伦博泰生物医药股份有限公司 杂环化合物治疗与ret基因改变相关疾病的用途和方法
WO2025256440A1 (zh) * 2024-06-14 2025-12-18 四川科伦博泰生物医药股份有限公司 含杂环化合物富马酸盐的制备方法
WO2026017002A1 (zh) * 2024-07-16 2026-01-22 四川科伦博泰生物医药股份有限公司 以杂环化合物为活性成分的药物组合物、其制备方法及用途
GB202410599D0 (en) * 2024-07-19 2024-09-04 Ellipses Pharma Ltd Therapeutics useful synergistic combinations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101166734A (zh) * 2005-02-28 2008-04-23 日本烟草产业株式会社 具有Syk抑制活性的新型的氨基吡啶化合物
BRPI0607062A2 (pt) * 2005-02-28 2009-08-04 Japan Tobacco Inc composto de aminopiridina com atividade inibidora de syk, composição farmacêutica e agente terapêutico compreendendo os mesmos
WO2008013622A2 (en) * 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
US20080234267A1 (en) * 2007-03-20 2008-09-25 Karen Elizabeth Lackey Compounds and Methods of Treatment
JP2010208945A (ja) * 2007-06-01 2010-09-24 Mitsubishi Tanabe Pharma Corp 複素環化合物
CN102812022B (zh) * 2010-01-12 2016-02-03 Ab科学有限公司 噻唑和噁唑激酶抑制剂
JP2013107824A (ja) * 2010-03-17 2013-06-06 Dainippon Sumitomo Pharma Co Ltd 新規単環ピリミジン誘導体
WO2012057262A1 (ja) * 2010-10-28 2012-05-03 日本新薬株式会社 ピリジン誘導体及び医薬
WO2012154518A1 (en) * 2011-05-10 2012-11-15 Merck Sharp & Dohme Corp. Bipyridylaminopyridines as syk inhibitors
US10202365B2 (en) * 2015-02-06 2019-02-12 Blueprint Medicines Corporation 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
RS65069B1 (sr) 2015-11-02 2024-02-29 Blueprint Medicines Corp Inhibitori ret-a
TWI704148B (zh) * 2016-10-10 2020-09-11 美商亞雷生物製藥股份有限公司 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
JP6888101B2 (ja) * 2017-01-18 2021-06-16 アレイ バイオファーマ インコーポレイテッド RETキナーゼ阻害剤としての置換ピラゾロ[1,5−a]ピラジン化合物

Similar Documents

Publication Publication Date Title
RU2178414C2 (ru) Производные пиперазина и пиперидина и способ их получения
AU728329B2 (en) New substituted biphenyl or phenylpyridine compounds, a process for their preparation and pharmaceutical compositions containing them
JP7579253B2 (ja) 甲状腺ホルモン受容体ベータアゴニスト化合物
US6028085A (en) Indole derivatives as 5-HT receptor antagonist
JP3397320B2 (ja) 縮合イミダゾリウム誘導体
PT605228E (pt) Derivados tiazolidinadionas sua preparacao e sua utilizacao
JP7408819B2 (ja) イソインドリン誘導体、並びにその医薬組成物及び使用
EP1656351B1 (en) Process for preparation of 4-aryl-nicotinamide derivatives
AU2018353122B2 (en) Amine-substituted heterocyclic compounds as EHMT2 inhibitors, salts thereof, and methods of synthesis thereof
KR930005992A (ko) 루코트리엔 생합성 억제제
WO2002102778A1 (en) Phenylpyridine carbonyl piperazine derivative
RU2197488C2 (ru) Производные пиперазина
WO2007129111A1 (en) Diazepine derivatives as 5-ht2a antagonists
US4713387A (en) Vasodilating and platelet aggregation inhibiting 1,4 dihydropyridines with an imidazolyl or pyridyl containing ester
JPH04321677A (ja) 新規の2−メトキシフェニルピペラジン誘導体
US5852019A (en) Pyrimidinylpyrazole derivatives
JP2024511389A5 (enExample)
EP0511031B1 (fr) Dérivés d'aryl-3 oxazolidinone, leur procédé de préparation et leur application en thérapeutique
JPH0321553B2 (enExample)
US5084456A (en) Oxazolopyridine compounds
CZ177892A3 (en) AMINOMETHYL SUBSTITUTED 2,3-DIHYDROPYRAN(2,3-b)PYRIDINES, PROCESS OF THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
Milcent et al. Reactions of sulfur monochloride with some aromatic aldehyde semicarbazones and thiosemicarbazones: New syntheses of substituted 2, 4‐dihydro‐1, 2, 4‐triazol‐3‐ones, 2, 4‐dihydro‐1, 2, 4‐triazole‐3‐thiones and 2‐amino‐1, 3, 4‐oxadiazoles
JPH03190872A (ja) 新規なチオフェン誘導体
WO2012107831A1 (en) Method of making a pyridone compound, 5-ethyl-1-phenyl-2-(1h)-pyridone, and intermediates thereof
RU2021124417A (ru) Гетероциклическое соединение, фармацевтическая композиция, содержащая его, способ его получения и его применение